Still, he rates J&J stock an outperform with a 290 price target. IBD Newsletters. Get exclusive IBD analysis and actionable news daily. SIGN UP NOW!
Still, he rates J&J stock an outperform with a 290 price target. IBD Newsletters. Get exclusive IBD analysis and actionable news daily. SIGN UP NOW!